Preliminary PET/CT Imaging with Somatostatin Analogs [68Ga]DOTAGA-TATE and [68Ga]DOTAGA-TOC
- 27 March 2017
- journal article
- research article
- Published by Springer Nature in Molecular Imaging and Biology
- Vol. 19 (6) , 878-884
Abstract
Somatostatin receptor positron emission tomography/X-ray computed tomography (SSTR-PET/CT) is a well-established technique for staging and detection of neuroendocrine tumors (NETs). Ga-68-labeled DOTA-conjugated octreotide analogs are the privileged radiotracers for diagnosis and therapeutic monitoring of NETs. Hence, we were interested in assessing the influence of promising, newer variant DOTAGA on the hydrophilicity, pharmacokinetics, and lesion pick-up of somatostatin analogs. Herein, the potential of ([68Ga]DOTAGA, Tyr3, Thr8) octreotide ([68Ga]DOTAGA-TATE) and ([68Ga]DOTAGA, Tyr3) octreotide ([68Ga]DOTAGA-TOC) as NET imaging agents has been investigated.Keywords
This publication has 29 references indexed in Scilit:
- Pharmacokinetic Properties of Peptidic Radiopharmaceuticals: Reduced Uptake of (EH)3-Conjugates in Important OrgansJournal of Nuclear Medicine, 2013
- The untapped potential of Gallium 68-PET: The next wave of 68Ga-agentsApplied Radiation and Isotopes, 2013
- Effects of Chelator Modifications on 68Ga-Labeled [Tyr3]Octreotide ConjugatesMolecular Imaging and Biology, 2013
- Gallium-68: Chemistry and Radiolabeled Peptides Exploring Different Oncogenic PathwaysCancer Biotherapy and Radiopharmaceuticals, 2013
- Be spoilt for choice with radiolabelled RGD peptides: Preclinical evaluation of 68Ga-TRAP(RGD)3Nuclear Medicine and Biology, 2013
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- PET/CT with 68Gallium-DOTA-peptides in NET: An overviewEuropean Journal of Radiology, 2011
- 68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)Molecular Imaging and Biology, 2010
- The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide ScintigraphyJournal of Nuclear Medicine, 2010
- NODAGATOC, a New Chelator-Coupled Somatostatin Analogue Labeled with [67/68Ga] and [111In] for SPECT, PET, and Targeted Therapeutic Applications of Somatostatin Receptor (hsst2) Expressing TumorsBioconjugate Chemistry, 2002